Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. As trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the complex and variable needs of people with autoimmune diseases.
Requirements
- PhD, PharmD, or MD with training in CP, PK/PD, Pharmacology, and Pharmaceutical Sciences
- 5+ years of experience in the application of CP within the context of drug development in the healthcare industry
- Expertise with PK, PD, immunogenicity, drug-drug interactions (DDI), bioavailability (BA)/bioequivalence (BE), special populations, and dose selection
- Hands-on experience in pharmacometrics (PMx) tools and software (e.g., WinNonlin, NONMEM or Monolix, and R) for individual (e.g., noncompartmental analysis, NCA) and population PK/PD (PopPK/PD) analysis, modeling and simulations (M&S), and exposure-response (E-R)
- Previous experience with monoclonal antibody (mAb) therapeutics in autoimmune diseases is preferred
- Knowledge of current practices, regulatory requirements in clinical development, bioanalysis, biopharmaceutics, pharmacology, toxicology, and formulation development
- Excellent written and oral communication skills with meticulous attention to detail
Benefits
- Full range of medical, dental, vision, 401k, and other benefits
- Unlimited paid time off
- Parental leave